ArticleMolecular and clinical oncology2022

Prophylactic use of pegfilgrastim enables the management of severe neutropenia without dose delays in patients with metastatic colorectal cancer treated with TAS-102 plus bevacizumab.

Sawako Tamaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.